PL327617A1 - Compositions for and methods of treating osseous insufficiency - Google Patents
Compositions for and methods of treating osseous insufficiencyInfo
- Publication number
- PL327617A1 PL327617A1 PL96327617A PL32761796A PL327617A1 PL 327617 A1 PL327617 A1 PL 327617A1 PL 96327617 A PL96327617 A PL 96327617A PL 32761796 A PL32761796 A PL 32761796A PL 327617 A1 PL327617 A1 PL 327617A1
- Authority
- PL
- Poland
- Prior art keywords
- insufficiency
- compositions
- methods
- treating osseous
- osseous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US583095P | 1995-10-23 | 1995-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL327617A1 true PL327617A1 (en) | 1998-12-21 |
Family
ID=21717974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96327617A PL327617A1 (en) | 1995-10-23 | 1996-10-23 | Compositions for and methods of treating osseous insufficiency |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0866710A4 (en) |
| JP (1) | JP2000513324A (en) |
| KR (1) | KR19990067010A (en) |
| CN (1) | CN1201393A (en) |
| AU (1) | AU706262B2 (en) |
| BR (1) | BR9611210A (en) |
| CA (1) | CA2235481A1 (en) |
| CZ (1) | CZ115398A3 (en) |
| EA (1) | EA199800393A1 (en) |
| HU (1) | HUP9802319A3 (en) |
| NO (1) | NO981810L (en) |
| PL (1) | PL327617A1 (en) |
| WO (1) | WO1997015308A1 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL330814A1 (en) * | 1996-06-20 | 1999-06-07 | Regents Board Of | Compounds for and methods of delivering pharmaceutical preparations and their application |
| AU4988997A (en) * | 1996-10-23 | 1998-05-15 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| US6080779A (en) * | 1996-12-13 | 2000-06-27 | Osteoscreen, Inc. | Compositions and methods for stimulating bone growth |
| US6376476B1 (en) | 1996-12-13 | 2002-04-23 | Zymogenetics Corporation | Isoprenoid pathway inhibitors for stimulating bone growth |
| WO1999009986A1 (en) * | 1997-08-22 | 1999-03-04 | Kyowa Hakko Kogyo Co., Ltd. | 4-aminoquinazoline derivatives |
| US6649631B1 (en) | 1997-10-23 | 2003-11-18 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating bone deficit conditions |
| DE19812204A1 (en) * | 1998-03-19 | 1999-11-04 | Plantamed Arzneimittel Gmbh | Use of extracts from Cimicifuga racemosa and Belamcanda sinensis as an estrogen-like organ-selective drug without uterotropic effects |
| JP2000004882A (en) * | 1998-06-18 | 2000-01-11 | Hoechst Marion Roussel Kk | Human mp52 gene promotor and screening of useful substance using the same |
| US6462019B1 (en) | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
| US6902721B1 (en) | 1998-07-10 | 2005-06-07 | Osteoscreen, Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
| US6838436B1 (en) | 1998-07-10 | 2005-01-04 | Osteoscreen Inc. | Inhibitors of proteasomal activity for stimulating bone growth |
| US6462036B1 (en) | 1998-11-06 | 2002-10-08 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
| SK5282001A3 (en) * | 1998-11-06 | 2002-01-07 | Knoll Gmbh | Tricyclic pyrazole derivatives |
| WO2000078351A1 (en) * | 1999-06-18 | 2000-12-28 | Mitsubishi Pharma Corporation | Osteogenesis promoters |
| WO2001017562A1 (en) * | 1999-09-02 | 2001-03-15 | Yamanouchi Pharmaceutical Co., Ltd. | Osteogenesis promoting agents |
| KR100641802B1 (en) | 1999-12-28 | 2006-11-02 | 에자이 가부시키가이샤 | Heterocyclic compounds having sulfonamide groups |
| FR2806408B1 (en) * | 2000-03-17 | 2002-10-11 | Oreal | COSMETIC COMPOSITION COMPRISING A DERIVATIVE OF FURANE- NAPHTOQUINONE, THEIR USE AS COLORING AGENT AND DERIVATIVES |
| ES2254836T3 (en) | 2000-06-05 | 2006-06-16 | Austria Wirtschaftsservice Gesellschaft Mit Beschrankter Haftung | HETEROCICLIC HYDRAZONS AS ANTI-TARGET ACTIVE PRINCIPLES. |
| US6660737B2 (en) | 2001-05-04 | 2003-12-09 | The Procter & Gamble Company | Medicinal uses of hydrazones |
| US7119120B2 (en) | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
| AU2003220935A1 (en) * | 2002-04-03 | 2003-10-13 | Sumitomo Pharmaceuticals Company, Limited. | Benzamide derivatives |
| US20050260126A1 (en) * | 2002-08-30 | 2005-11-24 | Yukitsuka Kudo | Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| AU2003284492A1 (en) * | 2002-12-16 | 2004-07-09 | Bf Research Institute, Inc. | Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| US20040192728A1 (en) | 2003-02-03 | 2004-09-30 | Ellen Codd | Quinoline-derived amide modulators of vanilloid VR1 receptor |
| KR20070008709A (en) | 2004-04-30 | 2007-01-17 | 다케다 야쿠힌 고교 가부시키가이샤 | Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| JP2008530229A (en) | 2005-02-17 | 2008-08-07 | ワイス | Cycloalkyl fused indole, benzothiophene, benzofuran and indene derivatives |
| US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
| WO2009076792A1 (en) | 2007-12-19 | 2009-06-25 | Givaudan Sa | Cooling compounds |
| PL2346837T3 (en) | 2008-06-26 | 2015-07-31 | Resverlogix Corp | Methods of preparing quinazolinone derivatives |
| ES2463097T3 (en) | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| US20110319416A1 (en) * | 2009-01-28 | 2011-12-29 | Emory University | Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions |
| EP2408454A2 (en) | 2009-03-18 | 2012-01-25 | Resverlogix Corp. | Novel anti-inflammatory agents |
| NZ596117A (en) | 2009-04-22 | 2014-10-31 | Resverlogix Corp | Novel anti-inflammatory agents |
| ES2745471T3 (en) | 2011-11-01 | 2020-03-02 | Resverlogix Corp | Oral immediate-release formulations for substituted quinazolinones |
| WO2014012889A1 (en) | 2012-07-18 | 2014-01-23 | University College Dublin - National University Of Ireland, Dublin | Anti-angiogenic compounds |
| CN102942515A (en) * | 2012-10-22 | 2013-02-27 | 暨南大学 | Ethane bridged indole compound, synthetic method and application thereof |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
| AU2013365926B9 (en) | 2012-12-21 | 2019-01-17 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| CN114984016A (en) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | Compositions and methods for treating complement-associated diseases |
| CN107019687B (en) * | 2017-05-08 | 2020-10-27 | 上海市伤骨科研究所 | Application of N- (4-chlorphenyl) -3-hydroxy-2-naphthamide compound |
| CN111116552B (en) * | 2020-01-17 | 2022-10-11 | 河北科技大学 | Quinazolinone compound and preparation method thereof |
| CN114469863B (en) * | 2021-11-26 | 2023-09-26 | 南方医科大学南方医院 | Use of sterol liposomes as drug delivery systems for dental pulp and dentin |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4889851A (en) * | 1986-11-21 | 1989-12-26 | Fujisawa Pharmaceutical Co, Ltd. | Benzothiadiazine compounds, and pharmaceutical composition comprising the same |
| JP2724396B2 (en) * | 1987-12-18 | 1998-03-09 | 武田薬品工業株式会社 | Osteoporosis prevention and treatment agent |
| WO1992000071A1 (en) * | 1989-02-10 | 1992-01-09 | Washington Research Foundation | Immunoregulatory agents |
| JPH06192272A (en) * | 1992-12-24 | 1994-07-12 | Japan Tobacco Inc | New triazolobenzothiadiazine and triazolobenzothiadiazepine derivative |
| US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
| EP0716086A1 (en) * | 1994-12-09 | 1996-06-12 | Boehringer Mannheim Gmbh | Malonic acid based matrix metalloproteinase inhibitors |
| AU4988997A (en) * | 1996-10-23 | 1998-05-15 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| US6022887A (en) * | 1996-12-13 | 2000-02-08 | Osteoscreen, Inc. | Compositions and methods for stimulating bone growth |
-
1996
- 1996-10-23 AU AU74710/96A patent/AU706262B2/en not_active Ceased
- 1996-10-23 KR KR1019980702947A patent/KR19990067010A/en not_active Application Discontinuation
- 1996-10-23 JP JP09516761A patent/JP2000513324A/en active Pending
- 1996-10-23 HU HU9802319A patent/HUP9802319A3/en unknown
- 1996-10-23 EA EA199800393A patent/EA199800393A1/en unknown
- 1996-10-23 PL PL96327617A patent/PL327617A1/en unknown
- 1996-10-23 WO PCT/US1996/017019 patent/WO1997015308A1/en not_active Application Discontinuation
- 1996-10-23 EP EP96936906A patent/EP0866710A4/en not_active Withdrawn
- 1996-10-23 CA CA002235481A patent/CA2235481A1/en not_active Abandoned
- 1996-10-23 CN CN96197827A patent/CN1201393A/en active Pending
- 1996-10-23 BR BR9611210-7A patent/BR9611210A/en not_active Application Discontinuation
- 1996-10-23 CZ CZ981153A patent/CZ115398A3/en unknown
-
1998
- 1998-04-22 NO NO981810A patent/NO981810L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO981810L (en) | 1998-06-22 |
| NO981810D0 (en) | 1998-04-22 |
| EP0866710A1 (en) | 1998-09-30 |
| HUP9802319A3 (en) | 1999-12-28 |
| CZ115398A3 (en) | 1998-12-16 |
| WO1997015308A1 (en) | 1997-05-01 |
| BR9611210A (en) | 1999-12-28 |
| KR19990067010A (en) | 1999-08-16 |
| EA199800393A1 (en) | 1998-12-24 |
| AU7471096A (en) | 1997-05-15 |
| JP2000513324A (en) | 2000-10-10 |
| AU706262B2 (en) | 1999-06-10 |
| EP0866710A4 (en) | 2001-07-11 |
| HUP9802319A2 (en) | 1999-02-01 |
| CN1201393A (en) | 1998-12-09 |
| CA2235481A1 (en) | 1997-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL327617A1 (en) | Compositions for and methods of treating osseous insufficiency | |
| PL324970A1 (en) | Method of and composition for treating asthma | |
| PL320487A1 (en) | Haemorrhoidal compositions and method of applying them | |
| AU5439996A (en) | Compositions and methods for treating pain | |
| ZA977564B (en) | Method of treatment | |
| EP0693908A4 (en) | Method and apparatus for installation of dental implant | |
| EP0758242A4 (en) | Composition and method for treatment of cmv infection | |
| US5656608B1 (en) | Amino acid compositions and methods of treatment using same | |
| EP0933803A4 (en) | Method of plasma treatment | |
| PL327600A1 (en) | Method of treating depressions | |
| PL317197A1 (en) | Compositions for and method of treating sclerosis multiplex | |
| GB9707693D0 (en) | Novel method of treatment | |
| EP0835092A4 (en) | Composition and treatment for baldness | |
| ZA963073B (en) | Coating compositions and methods of using them | |
| AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes | |
| GB9618341D0 (en) | Method of treatment | |
| GB9507825D0 (en) | Method of treatment | |
| EP0763143A4 (en) | Method of treating titanium parts | |
| PL326924A1 (en) | Compositions for and methods of preventing and treating mouth mucositis | |
| AU7379296A (en) | Method and composition for treatment of osteoporosis | |
| GB9415902D0 (en) | Method of treatment | |
| EP0692965A4 (en) | Method and composition for treatment of osteoporosis | |
| EP0929540A4 (en) | Antitumor compositions and methods of treatment | |
| GB9407335D0 (en) | Method of treatment | |
| GB9500396D0 (en) | Method of treatment |